OncoSynergy Crowdfunds Ebola Treatment

August 22, 2014 | Posted by Tess Mayall in Scientist Profile |

Can We Defeat EBOLA with an Experimental CANCER Drug? from Experiment on Vimeo.

We are proud to share that Science Exchange user, OncoSynergy, is crowdfunding to test their experimental cancer drug, OS 2966, against ebola infection.

OS2966 is a monoclonal antibody that inhibits CD29 , a main cellular adhesion receptor that is key to cancer progression. Interestingly, CD29  is also thought to be hijacked by the ebola virus during infection. With the current ebola outbreak’s death toll exceeding 1,000 victims, it is more important than ever that promising drugs are investigated as soon as possible. As a result, OncoSynergy is using the Science Exchange network to test whether OS2966 can block ebola infection in cultured human cells.

“We have a unique opportunity to potentially effect a major impact on the current global ebola crisis,” said
Dr. W. Shawn Carbonell, MD, PhD, Founder and CEO of OncoSynergy. “However, as a seed stage
biotech startup with 6 employees, we don’t have the bandwidth to take on projects beyond our central
mission focused on cancer. We are teaming up with Science Exchange and Experiment to accomplish
the initial experiments which are an important first step towards possible clinical testing of OS2966. We
now need the public’s help to fund the work so we can start as soon as possible.”

“I am pleased to be working with Dr. Carbonell on this timely project,” said our CEO, Dr. Elizabeth Iorns. “This is a great example of how the Science Exchange platform can help facilitate science and accelerate scientific discoveries.”

If you’re interested in helping this research progress, please donate to OncoSynergy’s campaign here: https://experiment.com/projects/can-we-defeat-ebola-with-an-experimental-cancer-drug

Science Exchange Stories: OncoSynergy, fighting brain cancer as the family business

January 21, 2014 | Posted by Tess Mayall in Scientist Profile |
Shawn Carbonell, MD, PhD and wife Anne-Marie Carbonell, MD, OncoSynergy’s new VP of Clinical Development

Shawn Carbonell, MD, PhD and wife Anne-Marie Carbonell, MD, OncoSynergy’s new VP of Clinical Development

This week I got to catch up with our user Shawn Carbonell and his biotech company OncoSynergy, who has made exciting progress in the 2 months since we last talked. They were honored with the Children’s Humanitarian Award from the Children’s Tumor Foundation at their annual Gala in New York City and have just announced they are the Social Media Sponsor of the 2014 Race for Hope for brain cancer research held in conjunction with Accelerate Brain Cancer Cure (ABC2) and the National Brain Tumor Society. However, perhaps most importantly, Shawn Carbonell’s wife, Anne-Marie Carbonell, has joined the OncoSynergy team as Vice President of Clinical Development.

To put it in his words, “When I found out she was single and was no longer in neurosurgery I made it my mission to both marry her and hire her. Last month both became reality.”

There are so many fascinating elements to Anne-Marie. Both Shawn and Anne-Marie successfully matched into neurosurgery residency only to find new career tracks; they’re now making the fight against brain cancer the family business. That’s only a small fraction of the incredible story, read the rest below! Read the rest of this entry »

About Science Exchange

We are transforming scientific collaboration by creating a marketplace where scientists can order experiments from the world's top labs.

Check the Science Exchange blog for updates, opinions, guest posts and the latest happenings at Science Exchange HQ!

Visit Science Exchange →

Subscribe to the blog
Never miss a post! Science Exchange blog posts delivered right to your inbox.
Thank you for joining the SciEx revolution!
Powered By WPFruits.com